By GREGORY ZELLER // In a potentially huge breakthrough in the struggle against seasonal influenza mutations, Codagenix Inc. is preparing to release data demonstrating “multi-season efficacy” for its frontline flu…
By GREGORY ZELLER // With Zika virus, Foot and Mouth Disease and other global threats already in its crosshairs, Farmingdale biotech Codagenix Inc. is challenging another high-profile opponent: swine flu….
By GREGORY ZELLER // A Stony Brook startup that digitally recreates viruses in order to reprogram their genomes is preparing to take on the Zika virus, which World Health Organization…
By GREGOERY ZELLER // A seven-figure Regional Economic Development Council award is set to push an innovative influenza vaccine toward human trials. Codagenix, a 2012 startup cofounded by Farmingdale State…
By GREGORY ZELLER // Last year, when local venture firm Topspin chipped in on a $100,000 infusion for Stony Brook-based biotech Codagenix, it gave the startup a fairly clear idea…